author-photo

Xiaohong Zhang

Zhejiang University

46

Papers

511

Citations

Citation Trend

Filter By

Papers (34) Sort By

Journal Conference Others

Efficacy and Safety of the Biosimilar IBI301 Plus Standard CHOP (I-CHOP) in Comparison With Rituximab Plus CHOP (R-CHOP) in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): A Randomized, Double-Blind, Parallel-Group, Phase 3 Trial

2021 Advances in Therapy
Show All
- Source
- Cite
- Save
Citations (0)
Phase 1 studies comparing safety, tolerability, pharmacokinetics and pharmacodynamics of HLX01 (a rituximab biosimilar) to reference rituximab in Chinese patients with CD20-positive B-cell lymphoma.

2021 Chinese Journal of Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy and Safety of the Biosimilar IBI301 Plus Standard CHOP (I-CHOP) in Comparison With Rituximab Plus CHOP (R-CHOP) in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): A Randomized, Double-Blind, Parallel-Group, Phase 3 Trial

2021 Advances in Therapy
Show All
- Source
- Cite
- Save
Citations (0)
Treatment of Central Nervous System Relapse in Acute Promyelocytic Leukemia by Venetoclax: A Case Report.

2021 Frontiers in Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Dominant negative PD1 armored CART cells to induce remission in relapsed or refractory non-Hodgkin lymphoma (NHL) patients.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Pharmacokinetics and safety of IBI301 versus rituximab in patients with CD20+ B-cell lymphoma: a multicenter, randomized, double-blind, parallel-controlled study.

2020 Scientific Reports
Show All
- Source
- Cite
- Save
Citations (2)
Safety and Efficacy of Mitoxantrone Hydrochloride Liposome in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma and Extranodal NK/T-Cell Lymphoma: A Prospective, Single-Arm, Open-Label, Multi-Center, Phase II Clinical Trial

2020 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Safety and Efficacy of Mitoxantrone Hydrochloride Liposome in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma and Extranodal NK/T-Cell Lymphoma: A Multicenter, Single-Arm, Open-Label, Phase 2 Clinical Trial

2019 Blood
Show All
- Source
- Cite
- Save
Citations (1)
Primary central nervous system lymphoma in China: a single-center retrospective analysis of 167 cases

2019 Annals of Hematology
Show All
- Source
- Cite
- Save
Citations (3)
Three-year Follow-up on the Safety and Effectiveness of Rituximab Plus Chemotherapy as First-Line Treatment of Diffuse Large B-Cell Lymphoma and Follicular Lymphoma in Real-World Clinical Settings in China: A Prospective, Multicenter, Noninterventional Study

2018 Chinese Medical Journal
Show All
- Source
- Cite
- Save
Citations (3)